Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions

Clinical trial NCT01414426 · COMPLETED

Trial details

NCT number: NCT01414426
Sponsor: University of Chicago
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lip and Oral Cavity Squamous Cell Carcinoma Oral Cavity Verrucous Carcinoma Precancerous Condition

Start date: 2012-01-01
Primary completion: 2019-01-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.